
Sports Medicine
Preemptive periacetabular vs intraarticular bupivacaine for analgesia after arthroscopy
Arthroscopy. 2017 Jan;33(1):118-12442 patients with femoroacetabular impingement and scheduled for arthroscopic intervention were randomized to preemptive analgesia with either periacetabular bupivacaine injection or intraarticular bupivacaine injection. Patients were assessed for pain within 30 minutes after release from the postanaesthesia care unit, and up to 18 hours after surgery. Following discharge, pain was assessed daily for the first 14 days after surgery. Results demonstrated significantly lower pain scores at 30 minutes and 18 hours after surgery in the periacetabular group compared to the intraarticular group, but not at any time point in between, or thereafter. Tramadol consumption within the PACU was also significantly lower in the periacetabular group compared to the intraarticular group.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.